Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 27, 2024 11:39am
127 Views
Post# 36010949

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't know what it takes

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I don't know what it takesYes, that is what I am saying. Hopefully PWIB will comment on that as I am pretty sure he can offer better insight into this than myself. I don't think it has a high probability of happening but I am not sure what all the covenants might be that THTX might yet break. There is a reason why their financial filings still talk about a going concern risk but I am hopeful that language can soon disappear. THTX is in a much better financial spot than before the IQ offering and that should limit the risk of breaking another covenant. And if they were going to break one, it likely would have occurred in the first quarter when sales plummeted. So, this is probably very low risk stuff at this point if sales are rebounding as they have indicated they would via their guidance. But until that language does disappear from their filings, it is worth thinking about what it might mean. A lot depends on Marathon's attitude too should another covenant be broken. In the past, it was in Marathon's best interest to work with THTX to sort out covenant breeches since THJTX did not have the cash on the balance sheet they have now. With more cash now, it may be attractive to Marathon to bankrupt them on any further breech since it would be easier and lower risk now for Marathon to maximize their returns from the bankruptcy process. Now, Marathon has to consider their reputation as well and if they behave super aggressively towards THTX when that is not called for (and it is not called for in THTX's situation), they could easily scare away future business. By working with THTX, they actually enhance their reputation with future potential lenders. Since they will likely get all their money back in any event with THTX, they really have no reason to bankrupt THTX other than greed as their maximum possible return might be via what I have suggested via bankrupting and relisting. But with lenders like Marathon, greed is defintely a concern which we should consider. 
Trogarzon wrote: Reading this ain't encouraging at all.  So basically you are saying Marathon would bankrupt us and relist the company of wich we would'nt own any shares.  Is that. Loose all.


<< Previous
Bullboard Posts
Next >>